Kaj je HAS NOT BEEN EVALUATED v Slovenščini - Slovenski prevod

• ni bil ocenjen
• niso ovrednotili
• niso ocenili
• ni bila ovrednotena
• niso ocenjevali
• ni raziskana
• ni bila ocenjena
• ni bil ovrednoten
• ni bila ocenjevana
• niso preskušali
• niso preučevali

Primeri uporabe Has not been evaluated v Angleški in njihovi prevodi v Slovenski

Has not been evaluated.
Ni bila ocenjevana!

The maintenance of the effect has not been evaluated.
Vzdrževanja tega učinka niso ocenjevali.

However, has not been evaluated.
Žal, ni bila ocenjevana!

The clinical relevance of this effect has not been evaluated.
Klinični pomen tega učinka niso ovrednotili.

M-M-RVAXPRO has not been evaluated in fertility studies.
Cepiva M-M-RVAXPRO niso ovrednotili v študijah plodnosti.

The effect of ixekizumab on human fertility has not been evaluated.
Vpliva iksekizumaba na plodnost pri ljudeh niso ocenili.

Protective efficacy has not been evaluated in males(see section 5.1).
Pri moških zaščitnega učinka niso preučevaliglejte poglavje 5.

The effect of secukinumab on human fertility has not been evaluated.
Vpliva sekukinumaba na plodnost pri ljudeh niso ocenjevali.

The efficacy of Bexsero has not been evaluated through clinical trials.
Učinkovitost cepiva Bexsero ni bila ovrednotena v kliničnih preskušanjih.

The effect of race on metabolism of sodium oxybate has not been evaluated.
Vpliva rase na presnovo natrijevega oksibata niso ovrednotili.

Lapatinib has not been evaluated in patients with symptomatic cardiac failure.
Lapatiniba niso ocenjevali pri bolnikih s simptomatskim srčnim popuščanjem.

Rights The copyright and related rights status of this Item has not been evaluated.
Status avtorske in sorodnih pravic na delu še ni bil ocenjen.

Umeclidinium bromide has not been evaluated in subjects with severe hepatic impairment.
Umeklidinijevega bromida niso ocenili pri preiskovancih s hudo okvaro jeter.

The influence of race on icatibant pharmacokinetics has not been evaluated.
Vpliva rase na farmakokinetične lastnosti ikatibanta niso preučevali.

Umeclidinium/vilanterol has not been evaluated in patients with severe hepatic impairment.
Kombinacije umeklidinij/vilanterol niso ocenili pri bolnikih s hudo okvaro jeter.

Concomitant administration of OAT3 inhibitors has not been evaluated in vivo.
So asna uporaba zaviralcev OAT3 in vivo ni bila ovrednotena.

STELARA has not been evaluated in patients who have undergone allergy immunotherapy.
Zdravila STELARA niso preskušali pri bolnikih, ki so prejeli imunoterapijo proti alergiji.

The influence of dialysis on the pharmacokinetics of ranolazine has not been evaluated.
Učinka dialize na farmakokinetiko ranolazina niso ocenjevali.

The pharmacokinetics of peginterferon beta-1a has not been evaluated in patients with hepatic insufficiency.
Farmakokinetike peginterferona beta-1a niso ocenili pri bolnikih z jetrno insuficienco.

The impact of shampooing on the efficacy of the veterinary medicinal product has not been evaluated.
Učinek šamponiranja na učinkovitost zdravila ni bil ocenjen.

Omidria has not been evaluated in the the absence of standard preoperative mydriatic and anesthetic agents.
Zdravila Omidria niso ovrednotili brez uporabe standardnih predoperativnih midriatikov in anestetikov.

The carcinogenic potential of eptifibatide has not been evaluated in long-term studies.
Kancerogenosti eptifibatida niso ovrednotili z dolgoročnimi študijami.

The need for dose adjustment in patients with hepatic impairment has not been evaluated.
Potrebe po prilagajanju odmerka pri bolnikih z okvaro jeter niso ocenili.

The carcinogenic potential of darbepoetin alfa has not been evaluated in long-term animal studies.
Kancerogenega potenciala darbepoetina alfa niso ocenili v dolgoročnih študijah na živalih.

Continuation of Gilenya in patients with macular oedema has not been evaluated.
Nadaljevanja zdravljenja z zdravilom Gilenya pri bolnikih z makularnim edemom niso ocenjevali.

The effect of renal impairment on dronedarone pharmacokinetics has not been evaluated in a specific study.
Vpliv okvare ledvic na farmakokinetiko dronedarona ni bil ocenjen v specifični študiji.

Pitolisant pharmacokinetics after repeated administration in patients with hepatic impairment has not been evaluated yet.
Farmakokinetike pitolizanta po ponavljajočem odmerjanju pri bolnikih z okvaro jeter še niso ovrednotili.

Concomitant use of Neupopeg with any chemotherapy agent has not been evaluated in patients.
Sočasne uporabe Neupopega s katerimkoli kemoterapevtskim sredstvom pri bolnikih niso ovrednotili.

Cardiovascular safety of cobimetinib in combination with vemurafenib has not been evaluated in vivo.
Kardiovaskularne varnosti kobimetiniba v kombinaciji z vemurafenibom niso ocenili in vivo.